Extract
In this edition of the European Respiratory Journal, a European Respiratory Society (ERS) task force adds to previously published guidelines for use of transbronchial lung cryobiopsy (TBLC) for diagnosis of interstitial lung disease (ILD) [1, 2]. Clinical guidelines are intended to outline best practices, frequently in areas for which high quality evidence is lacking. Methodologies for identifying and assessing the evidence are applied to a limited number of questions using standardised processes with clearly articulated roles and responsibilities for guideline participants to generate recommendations, often predicated on a combination of low or very low quality evidence and expert opinion.
Abstract
This editorial assesses the impact of newly published ERS guidelines for use of transbronchial cryobiopsy for diagnosis of interstitial lung disease, including future areas of research likely to facilitate ongoing global adoption https://bit.ly/3LAy1n8
Footnotes
Conflict of interest: None declared.
- Received August 22, 2022.
- Accepted September 15, 2022.
- Copyright ©The authors 2022. For reproduction rights and permissions contact permissions{at}ersnet.org